default author photo

Alexandre Bazinet

University of Texas at Houston - Department of Leukemia

SCHOLARLY PAPERS

1

DOWNLOADS

84

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Combination of Oral Decitabine/Cedazuridine and Venetoclax in Patients with Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Number of pages: 30 Posted: 21 Sep 2023
University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Miami - Sylvester Comprehensive Cancer Center, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Biostatistics, University of Texas at Houston - Department of Hematopathology, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia and University of Texas at Houston - Department of Leukemia
Downloads 84 (777,583)

Abstract:

Loading...

myelodysplastic syndromes, MDS, oral decitabine, venetoclax, chronic myelomonocytic leukemia, CMML